Document is current
Any future updates will be listed below
-
Authors
Boye, Kristina S.
Stewart, Katie D.
Matza, Louis S.
Soucier-Ernst, Danielle
Houle, Christy
Goetz, Iris
Patel, Hiren
Kanu, Chisom
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 27 November 2025
Accepted: 5 March 2026
First Online: 25 March 2026
Declarations
:
: All study methods, materials, and clinical sites were approved by an independent review board (Salus IRB, study number 24116). This study was conducted according to the principles of the Declaration of Helsinki. All participants provided informed consent before engaging in study procedures. The consent form notified participants that their data may be published, but they would not be personally identified in any publications. All participants were compensated for their time.
: All participants were informed about and provided approval for the use of their published data.
: Kristina Boye, Christy Houle, Iris Goetz, Hiren Patel, and Chisom Kanu are employed by and own shares in Eli Lilly and Company. Louis Matza, Katie Stewart, and Danielle Soucier-Ernst are employed by Thermo Fisher Scientific, which received funding from Lilly for the time spent conducting this research.
